|
||




* Institute of Histology and Embryology, Faculty of Medicine, University of Lisbon, 1699 Lisboa Codex, Portugal; and U2AF65 is an essential splicing factor that
promotes binding of U2 small nuclear (sn)RNP at the
pre-mRNA branchpoint. Here we describe a novel
monoclonal antibody that reacts specifically with
U2AF65. Using this antibody, we show that U2AF65 is
diffusely distributed in the nucleoplasm with additional
concentration in nuclear speckles, which represent subnuclear compartments enriched in splicing snRNPs and
other splicing factors. Furthermore, transient expression assays using epitope-tagged deletion mutants of
U2AF65 indicate that targeting of the protein to nuclear
speckles is not affected by removing either the RNA
binding domain, the RS domain, or the region required
for interaction with U2AF35. The association of
U2AF65 with speckles persists during mitosis, when
transcription and splicing are downregulated. Moreover, U2AF65 is localized to nuclear speckles in early
G1 cells that were treated with transcription inhibitors
during mitosis, suggesting that the localization of
U2AF65 in speckles is independent of the presence of
pre-mRNA in the nucleus, which is consistent with the
idea that speckles represent storage sites for inactive
splicing factors. After adenovirus infection, U2AF65 redistributes from the speckles and is prefferentially detected at sites of viral transcription. By combining adenoviral infection with transient expression of deletion
mutants, we show a specific requirement of the RS
domain for recruitment of U2AF65 to sites of active
splicing in the nucleus. This suggests that interactions
involving the RS region of U2AF65 may play an important role in targeting this protein to spliceosomes in
vivo.
Howard
Hughes Medical Institute, Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester,
Massachusetts 01605
This article has been cited by other articles:
|
|